Navigation Links
Permacol surgical implant

ProductsPermacol surgical implant
Company Tissue Science Laboratories Inc.
Item Permacol surgical implant
Features 
  • Permacol surgical implant is a sterile off white, moist, strong but flexible flat sheet of acellular porcine collagen and its constituent elastin fibres presented moist in sterile saline.
  • Permacol surgical implant comes ready to use in double vacuum packed aluminium foil/polyethylene sachets which are impermeable to oxygen, and is sterilised by gamma irradiation.
  • Permacol surgical implant is non allergenic and resistant to collagenase attack.
  • Permacol surgical implant has both CE and FDA approvals for use in the EU and USA as a permanent surgical implant in humans and is indicated for the reconstruction, recontouring and reformation of soft connective tissue and in surgical repair procedures such as abdominal wall hernias and defects.
Description Permacol surgical implant is a sterile off white, moist, tough but flexible flat sheet of acellular porcine collagen and its constituent elastin fibres presented moist in sterile saline. Permacol surgical implant comes ready to use in double vacuum packed aluminium foil/polyethylene sachets which are impermeable to oxygen, and is sterilised by gamma irradiation.

Porcine dermal collagen has an architecture very close to that of human tissue and as Permacol surgical implant in the sheet format is not a reconstituted form of collagen that 3-D architecture is maintained. A precisely controlled degree of cross-linking is introduced into the structure, making it resistant to collagenase enzymes responsible for the breakdown and resorption of implanted collagen. This unique feature enables surgeons to complete operations and procedures involving tissue reconstruction, recontouring and repair, with durable results.

Info Tissue Science Laboratories Inc.
Customer Service: 978- 722-1600

Related medicine products :

1. Microsurgical Instrument Tray
2. Microsurgical Cannula Holder Tray
3. Force EZ Electrosurgical Generator
4. Surgistat Electrosurgical Generator
5. Force FX Electrosurgical Generator
6. Surgistat II Electrosurgical Generator.
7. Microsurgical straight forceps
8. Microsurgical curved forceps
9. IDS-300 Electrosurgical Generator
10. IDS-200 Electrosurgical Generator
11. Finesse Electrosurgical Generator (100-120 VAC)
(Date:6/26/2017)... ... June 26, 2017 , ... Dr. Martin Bastuba, MD, FACS, ... with the Fertility Center of California, is pleased to announce the addition of ... and TESA (percutaneous testicular sperm extraction). These minimally invasive treatments are primarily used ...
(Date:6/26/2017)... ... 26, 2017 , ... If the devil is in the ... these days. According to recent estimates, 75 – 80% of the medical bills ... studies point to Electronic Health Records (EHR) with automated features designed to ease ...
(Date:6/25/2017)... ... June 25, 2017 , ... Republicans in the United States Senate on Thursday ... Better Care Reconciliation Act. It differs significantly from the American Health Care Act, which ... in committee, or the House will have to take up the Senate version as-is, ...
(Date:6/24/2017)... ... June 24, 2017 , ... Genes Advice, ... medications in select Florida and Texas doctors' offices and clinics. This breakthrough testing ... of genetic testing recognizes the role genes play in determining an individual's tolerance ...
(Date:6/23/2017)... ... June 23, 2017 , ... ... announced the launch of Care Management Alerts and Dashboards, an innovative new service ... Rhode Island. , RIQI’s Care Management Alerts and Dashboards provide near real-time data ...
Breaking Medicine News(10 mins):
(Date:6/7/2017)... 2017  Novavax, Inc., (Nasdaq: NVAX ) today ... trials of its RSV F protein recombinant nanoparticle vaccine candidate ... been published in the journal Vaccine ... prior scientific conferences). The Company previously announced top line ... developing the RSV F Vaccine with the goal of protecting ...
(Date:6/5/2017)... 5, 2017 The Cincinnati ... Pharmacy, Inc. (NYSE: DPLO), has been awarded a Top ... Results are based on an employee survey administered ... and workplace improvement. The survey measures several aspects of workplace ... ...
(Date:6/3/2017)... , June 3, 2017  Eli Lilly and ... that results from the Phase 3 MONARCH 2 ... & 6 inhibitor, in combination with fulvestrant, significantly ... fulvestrant alone in women with hormone-receptor-positive (HR+), human ... cancer who have relapsed or progressed after endocrine ...
Breaking Medicine Technology: